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Marshall syndrome – a challenge 
in medical practice
Cecilia Lazea, Rodica Manasia, Călin Lazăr*
Marshall syndrome (periodic fever, adenitis, pharyngitis, aphthae, PFAPA syndrome) is characterized by recurrent episodes of fever 
associated with aphthous stomatitis, cervical adenitis or pharyngitis. Although it is the most common cause of recurrent fever in 
children, the diagnosis is rarely established. The aim of this study was to describe a group of Romanian children with Marshall 
 syndrome. In seven children with PFAPA, the following methods were used: patient history, clinical examination, and determination 
of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and tumor necrosis factor α (TNF-α). The treatment consisted in 
prednisone at a dose of 1 mg/kg. The age at onset was 2.2 years and at diagnosis 4.8 years. The mean interval between episodes was 
3.1 weeks and the duration per febrile episode was 3.7 days. The patients presented with pharyngitis (100%), adenitis (100%) and 
aphthous lesions (57.1%). The mean ESR value was 31 mm/h, CRP 7.8 mg/dL and leukocytes 17700/mm3. TNF-α remained elevated 
between febrile episodes. Six patients treated with prednisone had favorable evolution. In conclusion, PFAPA should be suspected in 
children with periodic fever associated with pharyngitis, cervical adenitis and aphthous stomatitis.
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INTRODUCTION
Marshall syndrome (periodic fever, adenitis, pharyngitis, 
aphthae, PFAPA syndrome) consists of recurrent episodes of 
fever associated with aphthous stomatitis, pharyngitis and 
cervical adenitis. It was fi rst described in 1987 by Marshall 
and it is characterized by episodes of fever lasting for 3-6 
days with recurrence every 3-8 weeks, associated with at 
least one of the three main signs: aphthous stomatitis, cervi-
cal adenitis and pharyngitis (1, 2). The febrile episodes can 
spike to 39-40 ºC, with little or no response to common an-
tipyretics. Other symptoms may be present during fever 
 attacks, such as headache, joint pain, myalgia, nausea, vom-
iting and abdominal pain. Onset of the disease is before the 
age of 5 years and usually lasts up to the age of 10-11 years, 
but there are some cases diagnosed in adults (3, 4). Patients 
are asymptomatic between episodes and have normal 
growth and development (2, 3,5). The etiology is still un-
known, but studies on cytokine concentrations showed a 
signifi cant increase in serum proinfl ammatory cytokine 
 levels (interleukin (IL)-1b, IL-6 and tumor necrosis factor α 
(TNF-α)) during and between febrile episodes and reduc-
tion in anti-infl ammatory cytokine levels (IL-4 and IL-10) in 
these patients (6-8).
There are no diagnostic tests for PFAPA syndrome. The diag-
nosis is based on clinical criteria and exclusion of other pos-
sible causes of recurrent fever in children. During febrile at-
tacks, patients present elevation of white blood cells, with 
preponderance of neutrophils and of acute phase reactants. 
Procalcitonin has normal values during fl ares and this fi nd-
ing can exclude bacterial infection (9, 10). Between attacks, 
all infl ammatory parameters are normal.
The most eff ective methods of treatment are corticoster-
oids and tonsillectomy.
Although it is the most common cause of recurrent fever in 
children, the diagnosis is rarely established.
The aim of the present study was to assess clinical and labo-
ratory characteristics of seven children with PFAPA syn-
drome in order to review the criteria for its accurate diagno-
sis and to avoid unnecessary use of antibiotics.
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PATIENTS AND METHODS
Seven children (5 girls and 2 boys) with recurrent episodes 
of fever were evaluated for PFAPA syndrome. The diagnosis 
of PFAPA syndrome was established according to the crite-
ria proposed by Thomas: (a) regularly recurrent fever; (b) 
onset at an early age; (c) absence of upper respiratory tract 
infection; and (d) at least one of the following clinical signs: 
pharyngitis, aphthous stomatitis or cervical adenitis. Addi-
tional criteria included completely asymptomatic intervals 
between febrile episodes, normal growth and develop-
ment, and exclusion of cyclic neutropenia.
An informed consent was obtained from participants or 
their guardians prior to enrolment in the study and the prin-
ciples of human research ethics were fully respected. We 
recorded medical data for each patient. These included de-
mographic data and medical history of patients and their 
families; characteristics of febrile episodes; laboratory eva-
luation; and treatment used. For laboratory evaluation, we 
followed peripheral leukocyte count, C-reactive protein 
(CRP), erythrocyte sedimentation rate (ESR), procalcitonin, 
immunoglobulin and tumor necrosis factor alpha (TNF-α) 
concentration during and 10 days after fever attacks. The 
treatment consisted of prednisone at a dose of 1 mg/kg.
RESULTS
The main reason for hospitalization of children was recur-
rent pharyngitis for which they underwent repeated antibi-
otic treatments. The family medical history of the patients 
revealed PFAPA syndrome in one patient and autoimmune 
disease in another patient.
Clinical characteristics of PFAPA episodes in our patients are 
shown in Table 1. The mean age at onset of the disease was 
2.2±0.9 years; the mean age at diagnosis was 4.8±3.2 years; 
the mean duration of episodes was 3.7±0.7 days; the mean 
maximal temperature was 39.6±0.5 ºC; and the mean fre-
quency of febrile episodes was 3.1±0.8 weeks.
Laboratory evaluation of the patients during and between 
PFAPA episodes is shown in Table 2.
Quantitative immunoglobulin levels were normal in all chil-
dren.
Six children underwent treatment with prednisone at a 
dose of 1 mg/kg and the frequency of episodes decreased 
to once in 2 or 3 months. In one patient who failed to re-
spond to prednisone administration, tonsillectomy resulted 
in complete remission. 
DISCUSSION
We report on a group of Romanian PFAPA patients and their 
clinical and laboratory characteristics. Although PFAPA syn-
drome is nowadays considered as the most common of 
various auto-infl ammatory fever disorders and its clinical 
manifestations are well known, the diagnosis is rarely estab-
lished by pediatricians or primary care physicians and our 
patients underwent repeated unnecessary antibiotic treat-
ments because the disease is commonly confounded with 
bacterial pharyngitis.
All seven patients were evaluated for recurrent acute phar-
yngitis and two of them had a family history of autoimmune 
disease and PFAPA syndrome, similar to the prevalence re-
ported previously (11).
There are studies which suggest that PFAPA syndrome could 
have a genetic origin. This hypothesis is supported by the 
presence of MEFV (Mediterranean fever) gene mutations in 
a few patients with PFAPA syndrome (12). Other explana-
tions involve the presence of this disease in siblings and 
clinical similarity with other periodic fever syndromes of ge-
netic origin (12, 13). The disease occurs because of an ab-
normal immune response to infectious agents (virus) at the 
level of lymphoid organs (tonsils), which induce cell activa-
tion of innate immunity (12-14).
TABLE 1. Clinical spectrum of PFAPA episodes
Clinical characteristic Value
Age at onset (yrs) 2.2








Mean number of antibiotic courses 
in 12 months preceding diagnosis
6.5







Leukocytes (/mm3) <10 000 17 700 8 466
ESR (mm/h) <10 31 11.2
CRP (mg/L) <8 78 7
Procalcitonin (mg/dL) <0.5 <0.5 <0.5
TNF-α (pg/mL) <8.1 18.8 12.8
ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; 
TNF-α = tumor necrosis factor α
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We compared our group with the groups published in the 
literature (Table 3). The clinical presentation of our group 
showed a long period (2 years) between the clinical onset 
and diagnosis because general practitioners who are the 
fi rst to see the patients are not well acquainted with this 
entity. The mean duration of febrile episodes, the frequency 
of episodes and the mean maximal temperature were simi-
lar to those described previously (11, 15, 16). The patients 
were given more than 6 unnecessary treatments with anti-
biotics in 12 months preceding their presentation to our 
service. Clinical presentation included pharyngitis in all chil-
dren (57.1% of them with exudative pharyngitis), cervical 
adenopathy in all children, and aphthous stomatitis in 57.1% 
of children. During relapses, the patients presented eleva-
tion of white blood cells and acute phase reactants (ESR, 
CRP), which normalized between attacks. Procalcitonin did 
not increase during fever attacks. This indicates that an as-
sociation of high serum CRP with elevated leukocyte count 
and undetectable levels of procalcitonin could be used to 
distinguish PFAPA attack from bacterial infection (10). The 
levels of the proinfl ammatory cytokine TNF-α were elevated 
during and between PFAPA episodes, an observation that 
suggests dysregulation of the immune response in PFAPA 
syndrome, with continuous proinfl ammatory cytokine acti-
vation (7, 17).
In six children, corticosteroid administration (prednisone 1 
mg/kg) resulted in rapid resolution of fever, but did not pre-
vent subsequent episodes of fever and did not change the 
course of the disease. A large number of studies report that 
febrile attacks became less frequent after the treatment 
with corticosteroids (7, 18, 19). Other studies report on ben-
efi cial eff ects of cimetidine, colchicine or thalidomide, but a 
small number of patients were treated (7, 18-21). The role of 
tonsillectomy in PFAPA syndrome is controversial. The argu-
ments for tonsillectomy are preventing recurrence of epi-
sodes, increasing the intervals between relapses, reducing 
the severity of the clinical manifestations, and inducing 
complete remission in 56%-100% of cases. The arguments 
against tonsillectomy are spontaneous resolution of PFAPA 
syndrome, possible persistent symptoms, and possible re-
lapses after a period of remission. Therefore, tonsillectomy 
should be considered in case of intolerance or failure of the 
standard medical treatment (18-25).
CONCLUSION
Marshall syndrome should be suspected in children with 
periodic fever associated with pharyngitis, cervical adenitis 
and aphthous stomatitis. Although it is the most common 
cause of recurrent fever in children, it is commonly attribu-
ted to respiratory infection and the diagnosis is established 
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Number of patients 66 54 320 130 105 12 12 7
Age at onset (yrs) - 1.9 - 1.5 3.1 1.15 1.8 2.2
Age at diagnosis (yrs) - 3 - - - 3 - 4.8
Fever Recurrent 100% 100% 100% 100% 100% 100% 100% 100%
Duration (days) - 5.3 - 4.5 4.1 4 5.1 3.7
Periodicity (weeks) - 3.7 - - 4.2 3 5.5 3.1
Maximal temperature (ºC) - 40.1 - - - 40 - 39.6
Pharyngitis 65% 96% 100% 83.8% 85% 100% 91% 100%
Cervical adenitis 77% 61% 100% 83.8% 62% 83% 78% 100%
Aphthous stomatitis 67% 39% 68% 58.5% 38% 67% 65% 57.1%
Abdominal pain 45% 65% 18% 53.1% 41% 42% - 28.5%
Nausea, vomiting - 35% - 30.8% 27% - - -
Diarrhea 30% 13% - 29.2% - - - -
Arthralgia, myalgia - 22% 11% 43.8% - 17% - -
Headache - 46% 18% 40.8% 44% - - 28.5%
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S A Ž E T A K
Marshallov sindrom – izazov u kliničkoj praksi
C. Lazea, R. Manasia, C. Lazăr
Marshallov sindrom (periodična groznica, adenitis, faringitis, afte, sindrom PFAPA) obilježen je opetovanim epizodama groznice 
udružene s aftoznim stomatitisom, cervikalnim adenitisom ili faringitisom. Iako je to najčešći uzrok opetovane groznice u djece, ova 
se dijagnoza rijetko postavlja. Cilj ovoga ispitivanja bio je opisati skupinu rumunjske djece s Marshallovim sindromom. U sedmoro 
djece s PFAPA primijenjene su sljedeće metode: anamneza, klinički pregled te određivanje sedimentacije eritrocita (SE), C-reaktivnog 
proteina (CRP) i faktora tumorske nekroze alfa (TNF-α). Liječenje je provedeno prednisonom u dozi od 1 mg/kg. Dob pri nastupu 
PFAPA bila je 2,2 godine, a pri dijagnozi 4,8 godina. Srednja vrijednost intervala među epizodama PFAPA bila je 3,1 tjedan, a trajanja 
pojedine febrilne epizode 3,7 dana. Bolesnici su imali faringitis (100%), adenitis (100%) i aftozne promjene (57,1%). Srednja vrijednost 
SE bila je 31 mm/h, CRP 7,8 mg/dL i leukocita 17700/mm3. TNF-α je ostao povišen između febrilnih epizoda. Povoljan ishod zabilježen 
je u šestoro bolesnika liječenih prednisonom. U zaključku, na PFAPA treba posumnjati u djece s periodičnim groznicama udruženim 
s faringitisom, cervikalnim adenitisom i aftoznim stomatitisom.
Ključne riječi: Marshallov sindrom; groznica
